Dermatologicals

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…

International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…

In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…

The decline in consumers’ disposable income due to rising prices is dampening demand for consumer health products that are not seen as essential, such as many dermatologicals products. In the current economic climate in particular, Serbian consumers…

The social restrictions in Singapore at the start of the pandemic led to less time spent outside the home, and therefore less concern about looks. This contributed to volume and current value declines for hair loss treatments and medicated shampoos…